Get started
Live feed
PRReleasevia Quantisnow
HOOKIPA Pharma Inc. logo

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
HOOKIPA Pharma Inc. logo
HOOK
HOOKIPA Pharma Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2019
Get push alerts for HOOK

Follow HOOK and get a push notification the moment its next story breaks.

Full HOOK profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HOOK (HOOKIPA Pharma Inc.) and more on Quantisnow.